Patterson R, Greenberger P A, Patterson D R
Department of Medicine, Northwestern University Medical School, Chicago, Illinois.
Ann Allergy. 1991 Aug;67(2 Pt 1):138-42.
In spite of available pharmacologic therapy that controls even the most severe cases of asthma, the mortality rate from asthma continues to rise. Patients with potentially fatal asthma (PFA) must be identified and then treated in a manner that will prevent potentially fatal episodes of asthma. Such management will not result in control of patients with PFA when the patient is not compliant with the medical regimen. We report and classify ten PFA patients according to the apparent psychologic abnormality that resulted in, or contributed to the noncompliance. Some of these psychologic abnormalities in patients with PFA such as adolescent noncompliance, prednisonephobia or bipolar affective disorders may be responsive to a combination of medical and psychiatric management. Other psychiatric diseases that may occur in patients with PFA, such as antisocial personality disorders or schizophrenia, may have a poor prognosis even with combined medical and psychiatric care. The managing physician should be aware of the grave prognosis in such cases.
尽管现有药物疗法能够控制甚至最严重的哮喘病例,但哮喘死亡率仍在持续上升。必须识别出具有潜在致命性哮喘(PFA)的患者,然后以预防哮喘潜在致命发作的方式进行治疗。当患者不遵守医疗方案时,这种管理方式无法控制PFA患者。我们根据导致或促成不遵守医嘱的明显心理异常情况,报告并分类了10例PFA患者。PFA患者中的一些心理异常情况,如青少年不遵守医嘱、泼尼松恐惧症或双相情感障碍,可能对药物治疗和心理治疗相结合的方法有反应。PFA患者中可能出现的其他精神疾病,如反社会人格障碍或精神分裂症,即使采用药物和心理联合治疗,预后可能也很差。主治医生应意识到此类病例的严重预后。